In meeting the challenge of identifying trends and correlations that will improve patient treatment and enhance the decision-making and diagnostic skills of all the stakeholders, we have divided the work between 7 separate, but interconnected teams, Work Packages (WP), responsible for: Project Management, Outcomes Definition, Data Access, Analytics and Integrated Service Platform, Involvement of Patients, HTA and Regulators, Project Communication, Legal, Ethics and Governance, WP7 – Ethics requirements
Each WP is composed of cohorts of specialists and organizations/enterprises that represent high-level expertise in their particular fields.
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
